Company intelligence / Profile preview
Alteogen
Daejeon, Daejeon Metropolitan City/Daejeon-si/Yuseong-gu district, South Koreaalteogen.com ↗
- Ownership
- Private
- Employees
- ~149
- Development stage
- Other
01
Overview
Alteogen has multiple clinical-stage programs targeting serious diseases with a focus on long acting biologics, antibody-drug conjugates, and biosimilars. Its lead assets include a long acting growth hormone in Phase II trials and an ADC for breast cancer in Phase I. The company leverages proprietary platforms to develop next-generation biologics and has established partnerships with global pharmaceutical companies.
- Therapeutic areas
- OphthalmologyHematologyEndocrinologyOncology
- Modalities
- Long-acting recombinant proteins (biobetters)Monoclonal antibodies (mAbs)Antibody-drug conjugates (ADCs)Biosimilars
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Kissei Pharmaceutical – co-development of Eylea/Aflibercept biosimilar ALT-L9Cristalia – co-development of Herceptin/Trastuzumab biosimilar ALT-LS2Lynkogen – co-development partner mentioned for some pipeline assets.
Beyond the preview
Go deeper on Alteogen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alteogen.